Dexa Medica is primarily engaged in medicinals and botanicals activity. Its headquarters is located in Banten. The company was founded in 1969. Dexa Medica is a prominent pharmaceutical company in Indonesia, founded by Drs. Rudy Soetikno. The company has established itself as a leader in the development, manufacturing, and marketing of pharmaceutical products, focusing on both prescription and over-the-counter medications. Dexa Medica's primary business line is the production of pharmaceuticals, while its secondary line includes the development of herbal and botanical products. The company operates several manufacturing facilities across Indonesia, with a significant presence in Jakarta and other major cities. Dexa Medica's product portfolio includes a wide range of therapeutic categories, such as cardiovascular, anti-infective, and gastrointestinal medications. Some of its well-known brands include Stimuno, a popular immune booster, and HerbaKOF, a herbal cough remedy. Dexa Medica has expanded its global footprint, exporting its products to over 10 countries, including markets in Southeast Asia, Africa, and the Middle East. The company has formed strategic partnerships with international pharmaceutical firms to enhance its research and development capabilities and to access new markets. As a member of the Indonesian Pharmaceutical Association, Dexa Medica is committed to adhering to high standards of quality and safety in its operations. The company aims to improve public health through innovative and affordable healthcare solutions, guided by its vision to be a leading pharmaceutical company in the region.
Headquarters
Blok B7/B1 No. 5, Bintaro Jaya Sektor 7
Tigaraksa; Banten;
Postal Code: 15224
Contact Details: Purchase the PT Dexa Medica report to view the information.
Website: http://www.dexagroup.com, www.dexa-medica.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service